Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer
for Head and Neck Squamous Cell Carcinoma
Drug: Cemiplimab
Sites in New Orleans +10 more locations
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 18+
Code: NCT06980038·Phase 2·Recruiting·Listed May 2025